MTOR and cancer: Similarly, the expression of the NORAD was notably increased in cancer tissues and cells compared with that in normal tissues and cells in NSCLC, which regulates the proliferation, migration, and invasion capabilities of NSCLC cells by targeting the miR-520a-3p/PI3k/Akt/mTOR signaling pathways (Wan et al., 2020).